Latest Tourism News

Kelsian Group has completed the $149.9 million sale of its Tourism Portfolio to Journey Beyond, reducing pro forma leverage to approximately 2.0x. The transport operator has reset FY27 Underlying EBITDA guidance to $295 million-$310 million as it shifts towards commuter and contracted services.

International Equities Corporation Ltd (ASX:IEQ) returned to a statutory profit in FY2026, but the result was largely supported by discontinued tourism operations while continuing activities remained loss-making. An auditor’s material uncertainty warning and a new secured $1.2 million loan put liquidity at the centre of the investment case.

PPK Group has converted the sale of its Craig International Ballistics stake into a substantially stronger balance sheet, reporting a $19.2 million FY2026 profit and $27.7 million in cash. The challenge now is turning that one-off windfall into a durable operating business without overpaying or losing patience.

Kelsian Group delivered record FY26 earnings and lifted its fully franked dividend, while preparing to become a more focused bus, coach and ferry operator. The next test is execution: completing the conditional tourism sale, mobilising new contracts and delivering against FY27 EBITDA guidance.

Orthocell has recorded the first commercial sales of its Remplir nerve repair product in Thailand, opening a new market estimated at US$84 million. The launch gives the company another distributor-led growth channel, although near-term sales are expected to remain modest.

Kelsian has secured Treasurerial approval for the proposed sale of its Tourism Portfolio to Journey Beyond, removing a key regulatory condition. The transaction still requires contract consents and other conditions, with completion targeted for the first half of FY2027.

Eureka Group Holdings has secured $70.7 million from institutional investors to help fund its $123.8 million acquisition of six NSW communities. The remaining $9.5 million retail offer opens against a backdrop of upgraded FY27 earnings guidance, but also higher gearing and execution risk.

Kelsian’s proposed sale of its Tourism Portfolio to Journey Beyond has cleared the ACCC, removing a major regulatory condition before completion. The transaction still requires FIRB approval, contract consents and other conditions, with completion expected in 1HFY27.

Ingenia Communities Group has secured unconditional contracts to sell six New South Wales communities, releasing $124 million in capital that will be deployed into higher-growth projects and debt reduction.

Merino & Co. Limited has secured $1.01 million through a placement of 10.1 million shares at a slight premium, aiming to fund its new lifestyle sub-brand YÙE and the innovative YÙE+U botanical dye initiative.

AdAlta’s partner SHcell has gained regulatory approval to provide the BZDS1901 CAR-T therapy to advanced mesothelioma patients in China’s Hainan Boao Lecheng special access zone, marking a key milestone in real-world data collection and treatment availability.

Air New Zealand reported a $242 million net loss for FY2026, hit by soaring fuel prices and multi-year engine issues despite revenue growth and operational gains.